CHRNA5 Contributes to Hepatocellular Carcinoma Progression by Regulating YAP Activity

Hepatocellular carcinoma (HCC) is a major health concern worldwide. A better understanding of the mechanisms underlying the malignant phenotype is necessary for developing novel therapeutic strategies for HCC. Signaling pathways initiated by neurotransmitter receptors, such as α5-nicotinic acetylcho...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Yan, Ci, Hongfei, Du, Wei, Dong, Qiongzhu, Jia, Huliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877699/
https://www.ncbi.nlm.nih.gov/pubmed/35214008
http://dx.doi.org/10.3390/pharmaceutics14020275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877699/
https://www.ncbi.nlm.nih.gov/pubmed/35214008
http://dx.doi.org/10.3390/pharmaceutics14020275

Ejemplares similares